Tracked deals
14
14 tracked deals across 2019-2026.
Menlo Park, California, United States
Norwest is a leading venture and growth equity investment firm that works side-by-side with entrepreneurs, primarily focused on consumer, enterprise, and healthcare. The firm has offices in Menlo Park and San Francisco and has subsidiaries in India and Israel.
Tracked deals
14
14 tracked deals across 2019-2026.
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Growth capital
8 growth capital · 3 buyout · 3 recapitalization
Last 5 years
Supporting Data
Showing the 12 most recent of 14 tracked deals for Norwest Venture Partners.
TriSpan closed a single-asset continuation vehicle (CV) for Sugar Beets Inc., the company behind the 56-unit Maman café-bakery and lifestyle brand. The CV was led by Kline Hill Partners with participation from Norwest and a large Ivy League endowment, while TriSpan and its affiliates reinvested to support Maman’s next phase of national and international expansion.
Route 92 Medical, a neurovascular medical technology company, announced a $50 million growth financing round. Sectoral Asset Management joined the round alongside lead investor Novo Holdings and returning investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group to accelerate global commercial expansion and further clinical and product development.
Zelis, a Boston-based healthcare technology company, sold a minority stake to a group of investors led by Mubadala Investment Company and including Norwest and HarbourVest, with Parthenon and Bain Capital remaining the majority owners. The transaction closed November 26, 2024 and brings strategic capital and investor support to fuel Zelis's continued growth in healthcare payments and financial technology.
Novo Holdings led a $50 million investment in Route 92 Medical as a Series F extension, joining returning investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group. The financing will accelerate global commercialization of Route 92's neurovascular intervention product portfolio and support regulatory authorizations in new geographies; Novo Holdings' Noel Jee will join Route 92's board.
Envestnet, Inc. entered into a definitive agreement to be acquired by affiliates of vehicles managed or advised by Bain Capital, valuing the company at $4.5 billion ($63.15 per share). The deal received stockholder approval and closed in November 2024, taking Envestnet private and removing its common stock from public listing.
KKR (via a fund managed by the firm) has agreed to make a minority investment in Infinx Services Private Limited, an AI-driven healthcare revenue cycle management (RCM) provider based in Mumbai. Norwest Venture Partners, an existing investor, participated in the financing; proceeds will be used to accelerate growth, expand AI and analytics capabilities, broaden market reach in the U.S., and support bolt-on acquisitions.
Legion Technologies, a provider of AI-native workforce management software, raised $50 million in a growth round led by Riverwood Capital with participation from existing investors including Norwest, Stripes, Webb Investment Network and XYZ. The capital will be used to accelerate product R&D, expand go-to-market (including a European GTM team) and support international customer growth.
Sentinel Capital Partners has acquired SmartSign, an e-commerce leader in customizable signs, labels, and tags headquartered in Brooklyn, New York. Sentinel partnered with SmartSign's management team and incumbent investor Norwest (Norwest Venture Partners) to support SmartSign's continued organic and acquisitive growth; terms were not disclosed.
Qventus announced a $50 million growth capital round led by Thomas H. Lee Partners with a strategic partnership and investment from Premier, Inc.; ThedaCare and existing investors Bessemer Venture Partners, Mayfield, and Norwest Venture Partners also participated. The funding and partnership will help Qventus expand its AI-powered care-operations platform across additional hospitals and health systems and enable product enhancements that leverage Premier’s data assets.
Elligo Health Research completed the acquisition of ClinEdge (including GuideStar Research and BTC of New Bedford) as part of a $135 million financing led by Morgan Stanley Expansion Capital and Ally Bridge Group, with participation from Norwest Venture Partners and existing investors. The deal expands Elligo’s global scale and capabilities by combining ClinEdge’s research practice management and clinical services with Elligo’s IntElligo technology, EHR-derived data access, and trial-acceleration platform.
Bow River Capital’s Software Growth Equity Fund completed a recapitalization of AbsenceSoft with Norwest Venture Partners; terms were not disclosed. Bow River will retain a significant equity stake and a board seat while Norwest joins as a growth equity partner to support continued product and revenue expansion for the cloud-based absence management SaaS provider.
TPG Growth, Norwest Venture Partners and Evolvence India led a $33 million equity investment in Ess Kay Fincorp, a Jaipur-based non-bank finance company (NBFC) focused on commercial vehicle and small business lending across North and West India. The round — fully subscribed by existing investors — will support Ess Kay's next phase of growth, expanding its footprint, services and technology.
Turn tracked acquisition activity into an outreach-ready buyer list.